Navigation Links
Microneedles enhance drug administration through skin
Date:2/4/2008

LEXINGTON, Ky. (Feb. 4, 2008) − In what is believed to be the first peer-reviewed study of its kind involving human subjects, researchers at the University of Kentucky College of Pharmacy and the Georgia Institute of Technology have demonstrated that patches coated on one side with microscopic needles can facilitate transdermal delivery of clinically-relevant doses of a drug that normally cannot pass through the skin.

Reported in the journal Proceedings of the National Academy of Sciences, the study could help advance the use of microneedles as a painless method for delivering drugs, proteins, DNA and vaccines into the body. The research also found other advantages for the microneedles, including an ability to produce therapeutic drug levels with lower doses, and lowered production of metabolites that may cause side-effects.

This proof-of-concept study shows that microneedles work in humans for transdermal drug delivery, said Daniel Wermeling, associate professor in the Department of Pharmacy Practice and Science at UK's College of Pharmacy. Success with microneedles could cause us to rethink the convergence of the drug and delivery system and lead to a more integrated approach merging engineering with pharmaceutical technology.

The research was supported by the National Institutes of Health and the University of Kentucky Research Foundation.

This study represents an important landmark in the development of microneedles into drug delivery devices suitable for use in clinical medicine, said Mark Prausnitz, a professor in the School of Chemical and Biomolecular Engineering at the Georgia Institute of Technology. This method may be useful for a broad range of drugs that cannot normally be delivered without a hypodermic needle.

Transdermal drug delivery has proven successful in a number of applications, including pain management, congestive heart failure and hormone replacement. Transdermal administration offers advantages over o
'/>"/>

Contact: Ann Blackford
ann.blackford@uky.edu
859-323-6363
University of Kentucky
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. T cell immunity enhanced by timing of interleukin-7 therapy
2. Senate Finance Committee Recommends Ways That Medicare Can Enhance Current Physician Quality Reporting Initiative (PQRI)
3. Align Technology Launches Aligntech Institute to Help Invisalign Providers Enhance Treatment Success and Practice Economics
4. Companys Award-Winning Sound Enhancement Technology Proven to Provide Superior Performance Over Other Technologies; Patent Will Enhance Able Planet, LINX AUDIO Brands
5. Technique enhances digital television viewing for visually-impaired
6. Fusion Energy Teams Up With BPs am/pm Stores to Enhance Supercross Sponsorship and Fusion Energy Products Distribution
7. AAPPO and HCAA Form Partnership to Enhance Services to Meet the Changing Business Needs of PPOs and TPAs
8. Z-shaped incision enhances minimally invasive surgery
9. Z-shaped incision enhances minimally-invasive surgery
10. QLT Appoints Goldman, Sachs & Co. as financial advisor in review of strategic options to enhance shareholder value
11. Advanced Clinical Research Services Enhances Biostatistics Offering
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Microneedles enhance drug administration through skin
(Date:2/28/2015)... Javon Bea Mercy Health System CEO ... capable by the State of Illinois, enabling potential stroke ... Hospital. , The hospital was required to submit data ... stroke according to national standards of care for stroke ... bypass hospitals not designated as an Emergent Stroke Ready ...
(Date:2/28/2015)... 28, 2015 Memphis, TN: MedixSafe has ... for a new security reader named Guardian 2. ... is a new biometric scanner that significantly increases ... features, the new biometric scanner provides fast and ... , MedixSafe narcotics lockers with Vanguard ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 1Heart ... and showcased emerging brand at Houston Texas Franchise ... Las Vegas sending its executive delegates headed by ... Business Development and Training Randolph Clarito. , Franchise ... was held last February 4-7 and featured Franchise ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 ... Devices (IPD), has introduced miniature, wire bondable, silicon ESD ... Power LED markets. The ESD88NP and ... currents away from sensitive LED and IC products. ... Multilayer Varistors (MLV). All devices meet the requirements ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 ... “cutters”, are often misunderstood, misdiagnosed and therefore ... to healthy lives. Jacksonville-based addiction treatment ... of its highly acclaimed Lakeview Professional Lecture ... interested in understanding this complicated condition. ...
Breaking Medicine News(10 mins):Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3Health News:Lakeview Health to Host Important Workshop Tackling the Rising Issue of ‘Cutters’ on March 27 2
... Association for Cancer Research and the International Association for the ... M.D., for his leadership in lung cancer research at the ... conference, held from Jan. 11-14, 2010, drew more than 300 ... and the James Dudley chair in cancer research at the ...
... control in patients with type 2 diabetes, according to ... Chicago. The study "demonstrates for the first time ... OSA severity and glucose control in patients with type ... instructor of medicine at the University of Chicago. ...
... Serious complication called empyema has doubled in young children, ... Since the PCV7 early childhood vaccine for bacterial pneumonia ... number of children hospitalized for pneumonia because of pneumococcus ... decreased overall, new research shows. , But the scientists ...
... ... source of information for dental professionals on the latest trends in restorative materials, ... ... the leading provider of online daily news and information for the dental community, ...
... ... expatriates are calling MEDEX Global Group for assistance in trying to leave the country, ASI ... members of the press into the Haitian capital, Port-au-Prince. , ... ,Baltimore, MD (Vocus) January 14, 2010 -- In the ...
... PARK, Ill., Jan. 14 A new diagnostic tool, ... a pelvic mass is benign or malignant, is now available in ... in the assessment of epithelial ovarian cancer, the most lethal form ... ARCHITECT systems, is the first automated HE4 test available ...
Cached Medicine News:Health News:Lung cancer conference leaders honor Paul A. Bunn Jr., M.D. 2Health News:Obstructive sleep apnea may worsen diabetes 2Health News:Lung Infection Up in Wake of Kids' Pneumonia Vaccine 2Health News:DrBicuspid.com Announces 3M ESPE Exclusive Sponsorship of its Restoratives Community 2Health News:DrBicuspid.com Announces 3M ESPE Exclusive Sponsorship of its Restoratives Community 3Health News:An Earthquake Emergency: MEDEX and ASI Group Quickly Respond to the Situation in Haiti 2Health News:An Earthquake Emergency: MEDEX and ASI Group Quickly Respond to the Situation in Haiti 3Health News:Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test 2
(Date:2/27/2015)... , Feb. 27, 2015  Following a bipartisan ... that moved H.R. 284, the Medicare DMEPOS Competitive ... Association for Homecare (AAHomecare) released a statement praising ... to pass the legislation. "Today,s mark-up ... House Ways and Means Committee is a critical ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 ... EPI) and Bloom Burton & Co. Ltd. ("Bloom Burton") ... lock-up (the "Lock-Up") 2,353,130 common shares of the Company ... subject to the Lock-Up. Of the Common Shares released ... immediately upon release from the Lock-Up while the remainder ...
(Date:2/27/2015)...   Synageva BioPharma Corp. (Synageva) (NASDAQ: ... therapeutic products for rare diseases, joins the National ... for Rare Diseases™ (EURORDIS™), The Global Genes Project™, ... Disease Day. On the last day ... other participants conduct special events to raise awareness ...
Breaking Medicine Technology:Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6
... with investigators worldwide to develop new treatments for ... diverse forms of cancer - Plenary ... of patients with early-stage breast cancer, - Four oral sessions to feature ... study in renal cell ...
... Hispanics/Latinos, People ... with Diabetes and Obese Individuals, PARSIPPANY, N.J., ... presented at the American Society of,Hypertension,s Twenty- Third Annual ... powerful combination drug AZOR(TM),(amlodipine and olmesartan medoxomil) safely and ...
Cached Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7
Inquiry 4Fr, 5Fr and 6Fr diagnostic electrophysiology catheters offer simple, precise distal control with it's patented Easy-Hand steering mechanism....
... offers patient monitoring products for hospital ... medium acuity monitoring. The Envoy patient ... The Enmove monitor offers a ... complement the Envoy. The Ensemble ...
... The Mayfield Triad Skull Clamp, compatible with ... visual indication of clamping force on all ... user with the possibility of adjusting the ... can easily be increased or decreased by ...
Protein-to-creatinine ratio is key to earlier detection of Kidney Disease...
Medicine Products: